งานวิจัยของหน่วย

เขียนโดย: - เมื่อ : 2019-09-12 02:36:11 อ่านแล้ว: 1132 ครั้ง
  1. Suwanrath C, Thongphanang P, Pinjaroen S, Suwanugsorn S. Validation of modified World Health Organization classification for pregnant women with heart disease in a tertiary care center in southern Thailand. Int J Womens Health. 2018;10:47-53.
  2. Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, (Chamnarnphol N), et al. Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention. J Am Coll Cardiol. 2017 Jan 17;69(2):176-85.
  3. Bhatt DL, Stone GW, Mahaffey KW, Gibson CM, Steg PG, Hamm CW, (Chamnarnphol N), et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med. 2013;368(14):1303-13.
  4. Krittayaphong R, Winijkul A, Methavigul K, Wongtheptien W, Wongvipaporn C, Wisaratapong T, et al. Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study. BMC Cardiovasc Disord. 2018 Aug 25;18(1):174.
  5. Sawhney JP, Kothiwale VA, Bisne V, Durgaprasad R, Jadhav P, Chopda M, (Wisaratapong T, Cheewatanakornkul S), et al. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights into the GARFIELD-AF Registry. Indian Heart J. 2018 Nov - Dec;70(6):828-835.
  6. Rattanawong P, Vutthikraivit W, Charoensri A, Jongraksak T, Prombandankul A, Kanjanahattakij N, (Wisaratapong T), et al. Fever-Induced Brugada Syndrome Is More Common Than Previously Suspected: A Cross-Sectional Study from an Endemic Area. Annals of Noninvasive Electrocardiology. 2015; 21(2):136-41.
  7. Fitzmaurice DA, Accetta G, Haas S, Kayani G, Lucas Luciardi H, Misselwitz F, (Wisaratapong T, Cheewatanakornkul S), et al. Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists. Br J Haematol. 2016 Aug;174(4):610-23.
  8. Apiyasawat S, Tangcharoen T, Wisaratapong T, Yamwong S, Wiboonpolprasert S, Sritara P. CHA₂DS₂-VASc scores predict mortality after hospitalization for atrial fibrillation. International Journal of Cardiology. 2015 Apr 15;185:293-6.
  9. Kritsaneepaiboon S, Ina N, Chotsampancharoen T, Roymanee S, Cheewatanakornkul S. The relationship between myocardial and hepatic T2 and T2* at 1.5T and 3T MRI in normal and iron-overloaded patients. Acta Radiol. 2018;59(3):355-62.
  10. Asano T, Katagiri Y, Chang CC, Kogame N, Chichareon P, Takahashi K, et al. Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial: Feasibility, Diagnostic Performance of Quantitative Flow Ratio, and Clinical Prognostic Value of Functional SYNTAX Score Derived From Quantitative Flow Ratio in Patients With 3-Vessel Disease. JACC Cardiovasc Interv. 2019 Feb 11;12(3):259-70.
  11. Katsikis A, Chichareon P, Cavalcante R, Collet C, Modolo R, Onuma Y, et al. Application of the MADS classification system in a "mega mammoth" stent trial: Feasibility and preliminary clinical implications. Catheter Cardiovasc Interv. 2019 Jan 1;93(1):57-63.
  12. Asano T, Hytönen J, Chichareon P, Taavitsainen J, Kogame N, Katagiri Y, et al. Serial Optical Coherence Tomography at Baseline, 7 Days, and 1, 3, 6 and 12 Months After Bioresorbable Scaffold Implantation in a Growing Porcine Model. Circ J. 2019 Feb 25;83(3):556-66.
  13. Collet C, Miyazaki Y, Ryan N, Asano T, Tenekecioglu E, Sonck J, (Chichareon P), et al. Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CAD. J Am Coll Cardiol. 2018 Jun 19;71(24):2756-69.
  14. Katagiri Y, Onuma Y, Asano T, Chichareon P, Collet C, Miyazaki Y, et al. Relation between Bioresorbable Scaffold Sizing Using QCA-Dmax and Long-term Clinical Outcomes in 1,232 Patients from 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II). EuroIntervention. 2018 Oct 12;14(9):e1057-66.
  15. Modolo R, Miyazaki Y, Chichareon P, Asano T, Collet C, Tenekecioglu E, et al. Interventional cardiology: review of the year 2017. EuroIntervention. 2018 Apr 20;13(17):2083-96.
  16. Vranckx P, Valgimigli M, Jüni P, Hamm C, Steg PG, Heg D, (Chichareon P), et al. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet. 2018 Sep 15;392(10151):940-9.
  17. Collet C, Onuma Y, Sonck J, Asano T, Vandeloo B, Kornowski R, (Chichareon P), et al. Diagnostic performance of angiography-derived fractional flow reserve: a systematic review and Bayesian meta-analysis. Eur Heart J. 2018 Sep 14;39(35):3314-21.
  18. Asano T, Serruys PW, Collet C, Miyazaki Y, Takahashi K, Chichareon P, et al. Angiographic late lumen loss revisited: impact on long-term target lesion revascularization. Eur Heart J. 2018 Sep 21;39(36):3381-9.
  19. Asano T, Jin Q, Katagiri Y, Kogame N, Takahashi K, Chang CC, (Chichareon P), et al. A randomized comparison of healing response of the BuMA Supreme stent and Xience stent at one- and two-month follow-up: PIONEER-II OCT randomized controlled trial. EuroIntervention. 2018 Dec 20;14(12):e1306-15.
  20. Chichareon P, Krittayaphong R, Yindeengam A. Prevalence and predictors of appropriate implantable cardioverter defibrillator therapy in chronic left ventricular dysfunction patients for primary prevention of sudden cardiac death in Siriraj Hospital. Journal of the Medical Association of Thailand. 2015 Jan;98(1):14-20.
  21. Keeratichananont W, Nilmoje T, Keeratichananont S, Rittatorn J. Diagnostic yield and safety of sputum induction with nebulized racemic salbutamol versus hypertonic saline in smear-negative pulmonary tuberculosis. Therapeutic Advances in Respiratory Disease. 2015 Jul 23.

บทความที่เกี่ยวข้อง

ลิงค์ที่เกี่ยวข้อง